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Abstract
Formative research (i.e. focus groups and key informant interviews) was conducted to understand 
risk perceptions and identify barriers to participation in a case-control study of environmental 
exposures and genetic susceptibility as risk factors for multiple sclerosis (MS). Individuals with 
MS were recruited to participate in a focus group discussion and individual interviews. 
Participants were asked to review and comment on study materials and process including 
participation, interview, genetic testing, confidentiality, and questionnaire. A structured discussion 
guide was used with all participants to ensure uniformity and coverage of all predetermined topics. 
Participants reported an increased likelihood of participation if they were informed about the study 
by their neurologist and not a government agency. All participants expressed willingness to 
provide a blood sample for genotyping but disagreed about the setting for the blood draw (at home 
or in a lab). Participants were concerned that they would not receive their individual genotyping 
results. The study protocol and materials were revised based on comments from the focus group 
participants. Formative research is an under-utilized resource for researchers conducting 
epidemiologic studies. Even with limited resources, piloting study materials with individuals 
similar to the proposed study population can provide opportunities to make modifications to 
effectively meet the needs of participants and promote participation and retention.
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Recent advances in DNA technology have allowed new discoveries about the genetic basis 
of many diseases, including genetic susceptibility to common chronic diseases (1). The 
etiologic basis of most common diseases, however, is multifactorial, so even though a 
genetic mutation may increase risk, the disease is also influenced by environmental 
exposures, behaviors and other genes, and interaction between some or all etiologic factors 
(2). Epidemiologic studies play a key role in identifying these associations; however, 
achieving high participation rates in these studies has become increasingly more difficult 
(3). Before conducting such a study, researchers attempt to identify and address conditions 
that may pose particular challenges for participants that would decrease their likelihood of 
participation (3). For instance, it has been shown that contacting participants multiple times 
and providing choices improves recruitment (4).
The development of creative recruitment and retention techniques that optimize participation 
need to be customized to the targeted population (3). This is especially true in studies that 
collect a biologic specimen since the collection of specimens can be a barrier to participation 
(5, 6). Therefore, it is essential that potential barriers to participation are identified and 
addressed before a study is conducted.
Formative research (i.e. research conducted to examine behaviors, attitudes and practices of 
a target group, including exploring behavioral determinants) has been used to design 
effective public health activities using both qualitative and quantitative methods (6). These 
types of activities would be beneficial during the planning phase of epidemiologic studies to 
identify concerns, enhance participant recruitment, identify potential obstacles and test or 
validate questionnaires; however, they are not routinely used (7 - 10). Before conducting a 
case-control study of multiple sclerosis (MS) that included collecting a blood sample for 
genotyping, the Agency for Toxic Substances and Disease Registry (ATSDR), a federal 
public health agency, and the Texas Department of State Health Services (TDSHS) wanted 
to gain an understanding of risk perceptions potential participants may have that could 
impede study participation. Individuals with MS were identified and asked to participate in a 
focus group discussion or individual interviews, to learn about perceptions, attitudes, and 
beliefs related to the case-control study goals, recruitment methods, questionnaire topics, 
specimen collection, and dissemination of results.
Formative research was conducted to evaluate a proposed case-control study of MS. The 
purpose of this paper is to describe the focus group and interview process, including 
identification and selection of participants, group and telephone interview procedures, and 
modification of study materials. Results from the actual study that was conducted are 
provided to illustrate how the input from the focus group improved the study. We also 
provide lessons learned by the investigators and recommendations for other researchers who 
conduct community studies that include a genetic component.
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2.1. Proposed Case-Control Study
MS is a complex disease with a multi-factorial etiology, although the specific biological 
mechanism of the disease remains unknown. In the proposed study, participants would be 
asked to complete a questionnaire and provide a blood sample for genotyping. The 
questionnaire was designed to collect information pertaining to exposure to environmental 
factors thought to be associated with MS such as heavy metals, solvents and other toxic 
chemicals. It included a complete residential history, location of schools attended, 
occupational history and hobbies/lifestyle exposures. Information would also be collected 
regarding family history, medical history, reproductive history, and smoking. Cases would 
complete one extra section regarding the course of their disease. A blood sample would be 
obtained from all participants (cases and controls) to genotype single nucleotide 
polymorphisms (SNPs) in genes associated with MS. Genotyping results would be reported 
in summary form but not given back to individuals.
2.2. Focus Group Participants
Participants were individuals with MS who were identified in a cluster investigation in El 
Paso, Texas examining childhood exposure to heavy metals from a smelter and the risk of 
developing MS (11). At the end of the study, individuals identified with MS were asked if 
they would be willing to participate in future MS studies. Those individuals that agreed were 
contacted by TDSHS and asked to participate in a focus group.
2.3. Human Subjects
This project was determined to be exempt from human subjects regulations at 45 CFR 46 .
101(b)(2a) because interviews with adults were conducted which did not result in any 
identifiable data. Focus group participants provided verbal consent to participate and did not 
receive any compensation.
2.4. Setting
Two different sessions were held to accommodate the individuals who agreed to participate. 
First, an in-person focus group meeting was conducted at the TDSHS in Austin, Texas for 
those individuals who lived locally. Second, telephone discussions were conducted 
individually with those participants who lived outside the Austin area.
2.5. Procedures
For the in-person meeting, a circular sitting arrangement was used to reduce barriers and 
facilitate discussion and focus group members were introduced using only first names. The 
facilitator provided a brief overview of how the focus group discussion would proceed and 
described the background work the health department had conducted regarding multiple 
sclerosis in Texas. An overview of the proposed study, including the design, recruitment of 
study participants, data collection, genotyping, and confidentiality was also provided.
Participants were encouraged to provide their opinions and to explore their views with other 
participants. Participants were encouraged to speak freely and all the facilitators documented 
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responses. The discussion lasted approximately two hours. Telephone discussions were held 
the following day using the same outline as the in-person focus group and ranged from 30 
minutes to one hour.
Due to concerns of confidentiality on the part of the participants neither the focus group nor 
the telephone discussions were audio-taped. Facilitators took notes during the meeting to 
record opinions of the participants. Specific recommendations discussed during the meeting 
were reviewed before participants were dismissed to ensure accurate reporting.
2.6. Identifying Obstacles to Participation and Risk Perceptions
A structured discussion guide was used for both the focus group and the telephone 
interviews to ensure uniformity and coverage of all predetermined topics. All participants 
were asked for their opinions regarding the issues listed in Table 1.
2.7. Analytic Approach
After completion of the focus group and phone interviews, the facilitators discussed their 
overall impressions of the opinions of the participants around three themes: 1) reaction 
toward the study materials; 2) clarity and comprehensibility of the study materials; and, 3) 
participant consensus and divergent opinions regarding study materials. Each of the five 
topics discussed during the focus group and interviews was discussed until a consensus was 




Nine individuals participated in the focus group and interviews. Six individuals participated 
in the face-to-face session and three were interviewed by telephone. The majority of 
participants (n=8, 89%) were female and all participants were white. Disease progression 
was variable among participants with some having an aggressive form and others an 
asymptomatic progression.
3.2. Study Participation
Overall, participants expressed interest in participating in the proposed case-control study. 
All agreed they would be more likely to participate if they were informed about the study by 
their neurologist and not a government public health agency. There was also consensus that 
study participation would not be affected if the questionnaire was administered by phone or 
in-person.
3.3. Questionnaire
All participants stated that they would be willing to answer questions regarding their past 
residential history, school history, and hobbies. Concerns were raised about people who had 
lived in numerous places over the course of their lifetime or who had worked in numerous 
occupations or job settings. The participants felt that it would take an inordinate amount of 
time to obtain the necessary information and that people might not be able to complete the 
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entire questionnaire during one session. Questions were raised regarding specific portions of 
the questionnaire (i.e. symptoms of MS and types of medications taken) and what the 
responses would be used for. Participants felt strongly that the questionnaire should also 
include an open-ended question regarding what the individual felt caused their MS.
3.4. Blood Sample
Although all participants stated they would be willing to provide a blood sample for 
genotyping, they were not in agreement as to whether they would go to a lab to get their 
blood drawn. Individuals who did not have mobility problems were more willing to go to a 
lab to have their blood drawn, while those who had difficulty getting around stated that they 
would prefer to have someone come to their home to perform the blood draw.
3.5 Genotyping
All focus group participants were extremely upset when told that there were no plans to 
share individual results of the genotyping with study participants. Most of the focus group 
participants stated that they would not provide a blood sample if they would not receive their 
individual results.
3.6. Other Issues
Two other issues were identified during the focus group discussion:
1. All participants were concerned about protecting confidentiality including not 
identifying them as having MS and guaranteeing that their genotyping results 
would not be given to their insurance company or employer; and
2. Concern that some individuals with MS do not have the cognitive ability to answer 
the questions but could have legal guardians who could answer on their behalf.
3.7. Changes Made
Comments received from focus group participants were incorporated into the study protocol, 
study materials, and questionnaire. These included:
1. The introductory letter would be sent to potential participants from their neurologist 
and would not identify someone as having MS. The same letter would be sent to 
both cases and controls.
2. An information sheet was developed explaining the purpose of the study in a 
question and answer format.
3. Modification of the questionnaire included:
a) Specific time periods were added to the questions regarding residence, 
occupation etc. to limit the amount of responses;
b) an open-ended question of what a participant thought caused their MS 
was added;
c) the list with symptoms associated with MS was revised;
d) the medication section of the questionnaire was deleted.
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4. Study participants would have a choice where to have their blood drawn (i.e. at a 
lab or at home).
5. The introductory materials were revised to state more strongly that this study was 
research and the results of the genetic testing would not be provided to participants 
except in summary form since they have no clinical significance. The protocol was 
modified to state that if the genotyping information became clinically relevant then 
the results would be provided to study participants.
6. Confidentiality would be assured by including the study identification number only 
on the blood samples and only the Principal Investigator at ATSDR would have 
access to both questionnaire and genetic information.
7. Study participation would be limited to those with the cognitive ability to respond 
and answer questions.
8. A worksheet was developed for participants to complete before the questionnaire so 
that study participants would have time to obtain the necessary information.
9. Times for the phone interview would be flexible (i.e. day, night, weekends) and if 
the participant was unable to complete the questionnaire at one sitting the interview 
would be continued at a different time.
10. If a participant was unable to complete the questionnaire over the phone, a hard 
copy would be sent to them to complete.
11. The consent form was modified to include a separate section about storing the 
remaining blood sample for future studies of MS.
4. Conclusion
Conducting formative research can provide significant return to the study investigator and to 
study participants. In addition to insights provided from these activities to investigators, 
participants can pilot study materials allowing problems to be identified and corrected 
before study recruitment begins. It also allows investigators the opportunity to modify the 
protocol and materials to effectively meet the needs of potential study participants and 
promote participation. Utilizing individuals who are similar to the targeted participants in 
the proposed study is indispensable in making sure that the study materials are 
understandable and appropriate [9]. The result was that the majority of the participants in the 
case-control study that was completed in 2012 provided a blood sample for genotyping 
(91%) and consented to have their blood sample stored for future MS research (97.5%) 
[12].Feedback from our focus group participants indicated that the participatory process also 
provided a welcome opportunity for them to contribute to efforts to better understand the 
disease with the ultimate hope of benefitting others with MS and their families.
5. Discussion
Recruiting and retaining participants in epidemiologic studies is always a fundamental 
concern and vital to any study's success. However, conducting formative research before the 
onset of a study to obtain feedback on materials is not ordinarily done. Before embarking on 
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a case-control study of MS, we were worried about non-participation because study 
participants would be asked to provide a blood specimen for genotyping. To address this 
concern, we held discussions with individuals with MS and asked them to help to develop 
effective and sensitive study materials. Taking the time to conduct formative research can be 
beneficial even though adding another step in the study development takes time and 
resources, both of which are typically in limited supply.
The main strengths of the focus group discussions were that the individuals who participated 
represented the case population that would be targeted in the proposed study and that they 
were very open and forthcoming with their opinions. This openness could be attributed, at 
least in part, to the participants having the disease being investigated and being motivated to 
help improve the study. In addition, the facilitators were individuals they knew or had been 
in contact with and so rapport had already been established.
Some of the limitations of our approach were that we conducted a very simplistic focus 
group discussion with individuals who had MS but who were more positive toward the 
conduct of research activities. We also only conducted one focus group discussion which 
had a small sample size of homogeneous individuals. These limitations may have had an 
impact on the range of viewpoints that were collected and therefore on the changes made to 
the study materials.
Even with these limitations, the formative research provided us with information that was 
indispensable to the proposed case-control study. Feedback from participants indicated that 
the participatory process provided a welcome opportunity for them to contribute to efforts to 
better understand their disease with the ultimate hope of benefitting others with MS. There is 
always room for improvement so we recommend the following:
1. Budget time and resources to conduct multiple representative focus groups.
2. Be very clear about what you want to accomplish with the focus group discussion. 
Go through the study materials and identify areas that you want focus groups 
participants to comment on.
3. The questions posed to the focus group participants should not convey the bias of 
the investigators.
4. Make an agenda for the meeting and share it with participants so they know what is 
expected of them. Assure them that discussion is welcome and encouraged. Clearly 
defining areas you want to concentrate on will help make the analytic process more 
efficient.
5. Make sure all study personnel are available during the meeting.
6. Have participants review all study materials.
7. Make sure that the confidentiality of participants is protected at all times.
8. During the focus group discussion make sure everyone has the opportunity to speak 
– just because someone hasn't said something doesn't mean they agree with what is 
being said.
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Table 1
Discussion Guide Topic Outline
1 Would you be more likely to participate in this study if you were informed about it by a federal public health agency (ATSDR), the state 
health department or by your neurologist?
2 Would you be more likely to participate if the questionnaire was administered by phone or in person?











4 Would you be willing to have your blood drawn for genotyping?
5 Would you be willing to go to a lab to have your blood drawn or would you prefer to have someone come to your home?
6 How do you feel about not receiving the results of the genotyping?
7 Would you be willing to have your blood sample stored for future research on MS?
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